Anzeige
Mehr »
Login
Sonntag, 24.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CS50 | ISIN: BE0974386188 | Ticker-Symbol: 86C
München
22.11.24
08:13 Uhr
2,960 Euro
0,000
0,00 %
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOTALYS NV Chart 1 Jahr
5-Tage-Chart
BIOTALYS NV 5-Tage-Chart
RealtimeGeldBriefZeit
2,9403,06023.11.
GlobeNewswire (Europe)
208 Leser
Artikel bewerten:
(1)

Biotalys NV: Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer

Finanznachrichten News

Company Expands Senior Leadership Team with Experienced Agriculture Executive to Drive Partnerships

Ghent, BELGIUM, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Press Release

Biotalys ), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, is pleased to announce the appointment of Kamal El Mernissi as Chief Business Development Officer (CBDO).

"I'm delighted to welcome Kamal to the Executive Committee of Biotalys," saidSimon Moroney, Chairman of Biotalys. "With more than 15 years of experience in agriculture and a broad variety of leadership positions in marketing and sales, he is an excellent addition to the leadership team. The board looks forward to working with Kamal as he builds the company's roster of partnerships, with a focus on maximizing long-term value for Biotalys and its stakeholders."

"I had the pleasure of working with Kamal as part of my team at Marrone Bio Innovations and am delighted to welcome him to the executive leadership at Biotalys," said Kevin Helash, CEO of Biotalys. "Kamal and I have collaborated successfully in the past, and I'm thrilled that he has agreed to join Biotalys. As partnerships become increasingly important for us to bring our growing pipeline of novel and effective biocontrols to market, Kamal's expertise in fostering strong business relationships will be invaluable in the next phase of Biotalys' growth."

Most recently serving as the Vice President, Sales and Marketing North America at biocontrol solutions leader Marrone Bio Innovationstechnology platform to develop biofungicides and bio-insecticides with new modes of action.

Kamal El Mernissi, Chief Business Development Officer, said: "Biotalys is uniquely positioned to bring impactful innovation to farmers seeking performance and sustainability, and I am thrilled to start this new journey with such an incredible group of talented and mission-driven colleagues and investors. During my initial interactions, I was impressed by the team and sensed their excitement and motivation to develop protein-based biocontrols to positively impact the wider Ag community."

Prior to his role at Marrone, Mr. El Mernissi held various commercial leadership roles at Syngenta, where he was Portfolio Manager North America and LATAM, Commercial Unit head and Director of Sales for Morocco, and Asset Manager EMEA responsible for the launch a major active ingredient. Prior to that, he took up various roles in sales and marketing in leading companies such as DELL and SIKA. He obtained his Engineering Diploma in Agriculture from the Hassan II Agronomic and Veterinary Institute (Morocco) and his MBA at the University of California, Berkeley (United States).

The appointment of Kamal El Mernissi is effective as of 17 October 2024. Together with various colleagues from the Biotalys management, he will represent the company at the upcoming Annual Biocontrol Industry Meeting, taking place in Basel from 21 to 23 October.

About Biotalys

Biotalys is an Agricultural Technology.

For further information, please contact:

Toon Musschoot, Head of IR & Communication
T: +32

Important notices

Biotalys, its business, prospects and financial position remain exposed and subject to risks and uncertainties. A description of and reference to these risks and uncertainties can be found in the annual reporton the consolidated annual accounts published on the company's website.

This announcement contains statements which are "forward-looking statements" or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words 'aim', 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. Biotalys' actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by law.

Attachments

  • Biotalys Press Release Appointment CBDO - 17 October 2024 (https://ml.globenewswire.com/Resource/Download/348d143f-9bdd-4233-89ca-db506947a212)
  • Persbericht Biotalys stelt Kamal El Mernissi aan als CBDO - 17 oktober 2024 (https://ml.globenewswire.com/Resource/Download/98345ab2-6f79-4efe-8202-b9c64b2b76dd)

© 2024 GlobeNewswire (Europe)
Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!
Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.